Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction
This device is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction, also known as deep venous obstruction.
- This device is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction, also known as deep venous obstruction.
- Deep venous obstruction occurs when the veins in the deep venous system become obstructed, blocked and/or compressed causing restricted blood flow to the heart.
- The FDA approval is based on 12-month results from the ABRE clinical study, presented at the 2020 Charing Cross Symposium.
- "With FDA approval, we now have this important tool in our arsenal to treat patients with even the most challenging of deep venous lesions."